U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

PubAg

Main content area

You searched for: Journal name Vaccine Remove constraint Journal name: Vaccine Publication year rev 7978-2022 Remove constraint Publication year rev: 7978-2022 Source 2022 v.40 no.3 Remove constraint Source: 2022 v.40 no.3
Start Over

Search

23  Search Results

« Previous | 1 - 20 of 23 |
Number of results to display per page

Search Results

1. Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers

Author:
Marina Izak; Evgeniy Stoyanov; Keren Dezuraev; Eilat Shinar
Source:
Vaccine 2022 v.40 no.3 pp. 428-431
ISSN:
0264-410X
Subject:
COVID-19 infection; antibodies; females; fever; health services; injection site; males; observational studies; pain; vaccination; vaccines
Abstract:
... Currently approved anti-COVID-19 vaccines have been found to be safe and effective and almost 60% of Israeli residents are already vaccinated with BNT162b2 vaccine.This observational study was designed to evaluate the adverse events of vaccine reported by 61 healthcare workers at least 7 days after the 2nd vaccination, and to investigate the correlation of adverse events and anti-SARS-CoV-2 IgG an ...
DOI:
10.1016/j.vaccine.2021.11.082

2. Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States

Author:
Yuli Lily Hsieh; Summer Rak; Gillian K SteelFisher; Sebastian Bauhoff
Source:
Vaccine 2022 v.40 no.3 pp. 424-427
ISSN:
0264-410X
Subject:
COVID-19 infection; adults; surveys; time series analysis; vaccination; vaccines
Abstract:
... On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended “a pause in the use of this vaccine out of an abundance of caution.” We examined whether public attitudes toward COVID-19 vaccination shifted after this recommended suspension using an interrupted time series with data fr ...
DOI:
10.1016/j.vaccine.2021.11.085

3. Efficacy of BCG vaccine in animal models of neurological disorders

Author:
Davide Cossu; Stefano Ruberto; Kazumasa Yokoyama; Nobutaka Hattori; Leonardo A Sechi
Source:
Vaccine 2022 v.40 no.3 pp. 432-436
ISSN:
0264-410X
Subject:
BCG vaccine; Mycobacterium bovis BCG; animals; immune response; mechanism of action; sclerosis; vaccination
Abstract:
... The Bacillus Calmette-Guerin (BCG) vaccine can modulate the immune response via antigen-specific immune response, but also it can confer nonspecific protection and therapeutic benefits in several neurological conditions through different heterologous effects of vaccination. However, the precise mechanism of action of BCG remains unclear. In this review, different mechanisms underlying BCG-mediated ...
DOI:
10.1016/j.vaccine.2021.12.005

4. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006–2019. Temporal progression of serotypes distribution and antibiotic resistance

Author:
Jonathan Zintgraff; Paula Gagetti; Daniela Napoli; Nahuel Sanchez Eluchans; Lucia Irazu; Maria Moscoloni; Mabel Regueira; Claudia S. Lara; Alejandra Corso; Argentina Spn Working Group
Source:
Vaccine 2022 v.40 no.3 pp. 459-470
ISSN:
0264-410X
Subject:
Streptococcus pneumoniae; agar; antibiotic resistance; epidemiology; erythromycin; immunization; monitoring; morbidity; mortality; serotypes; vaccines; Argentina
Abstract:
... Streptococcus pneumoniae is a major cause of severe invasive disease associated with high mortality and morbidity worldwide. A total of 2908 pneumococcal isolates were analyzed between 2006 and 2019. Gold standard pneumococcal serotyping (the Neufeld-Quellung reaction) was performed to identify the serotypes associated with infection in children < 5 years in Argentina and agar dilution method was ...
DOI:
10.1016/j.vaccine.2021.12.008

5. Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake

Author:
Shaheen Kurani; Kathy L. MacLaughlin; Robert M. Jacobson; Jennifer L. St. Sauver; Gregory D. Jenkins; Chun Fan; Debra J. Jacobson; Jonathan Inselman; Xuan Zhu; Joan M. Griffin; Lila J. Finney Rutten
Source:
Vaccine 2022 v.40 no.3 pp. 471-476
ISSN:
0264-410X
Subject:
Papillomaviridae; cohort studies; humans; probability; socioeconomic status; vaccination; vaccines; Midwestern United States
Abstract:
... Despite availability of safe and effective human papillomavirus (HPV) vaccines, vaccination uptake remains low in the U.S. Research examining the impact of neighborhood socioeconomic status on HPV vaccination may help target interventions.To examine the association between area deprivation and HPV vaccine initiation and completion.Retrospective cohort study of individuals aged 11–18 years residing ...
DOI:
10.1016/j.vaccine.2021.12.003

6. The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis

Author:
Blanché Oguti; Asad Ali; Nick Andrews; Daan Barug; Duc Anh Dang; Scott A Halperin; Ha Thi Thu Hoang; Beth Holder; Beate Kampmann; Abdul M Kazi; Joanne M. Langley; Elke Leuridan; Naomi Madavan; Kirsten Maertens; Herberth Maldonado; Elizabeth Miller; Flor M Munoz-Rivas; Saad B. Omer; Andrew J. Pollard; Thomas F. Rice; Nynke Rots; Maria E. Sundaram; Nasamon Wanlapakorn; Merryn Voysey
Source:
Vaccine 2022 v.40 no.3 pp. 450-458
ISSN:
0264-410X
Subject:
World Bank; antigens; birth weight; blood; diphtheria; gestational age; half life; income; meta-analysis; models; tetanus; vaccination; vaccines; Belgium; Canada; Guatemala; Netherlands; Pakistan; Thailand; Vietnam
Abstract:
... There are few reliable estimates of the half-lives of maternal antibodies to the antigens found in the primary series vaccines. We aimed to calculate the half-lives of passively acquired diphtheria, tetanus and pertussis (DTP) antibodies in infants. We aimed to determine whether decay rates varied according to country, maternal age, gestational age, birthweight, World Bank income classifications, ...
DOI:
10.1016/j.vaccine.2021.12.007

7. Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data

Author:
Abdulellah M. Almohaya; Haya Alsubie; Bader Alqarni; Bashayer Alzayad; Ali Alghar; Khalid Alshahrani; Mazin Barry
Source:
Vaccine 2022 v.40 no.3 pp. 477-482
ISSN:
0264-410X
Subject:
COVID-19 infection; anaphylaxis; death; demographic statistics; females; headache; nausea; statistical analysis; syncope; vaccination; vaccines; Saudi Arabia
Abstract:
... Acute adverse events and anaphylaxis were reported after the administration of coronavirus disease (COVID-19) mRNA vaccines. We aim to explore the nature and outcome of adverse events following BNT162B2 vaccine in a community vaccination center, Riyadh, Saudi Arabia.Within 30 min post vaccination, all acute adverse events (AAEs) that occurred before March 31st, 2021, and in people older than 16 ye ...
DOI:
10.1016/j.vaccine.2021.12.001

8. Adverse event of Sinovac Coronavirus vaccine: Deafness

Author:
Hai Zhao; Yongtuan Li; Zhiyuan Wang
Source:
Vaccine 2022 v.40 no.3 pp. 521-523
ISSN:
0264-410X
Subject:
COVID-19 infection; Orthocoronavirinae; deafness; protective effect; vaccination; vaccines
Abstract:
... COVID-19 has spread worldwide and is one of the most threatening infectious diseases in the world. Vaccination is known as an effective method to protect susceptible populations against such diseases. The Coronavirus vaccine developed by Sinovac has been shown to have a high protective effect, but it also has potential adverse events. For example, our department saw two patients with reported case ...
DOI:
10.1016/j.vaccine.2021.11.091

9. Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study

Author:
Hyun Jin Kim; Heon Jeong Yun; Jungok Kim; Sungmin Kym; Qute Choi
Source:
Vaccine 2022 v.40 no.3 pp. 437-443
ISSN:
0264-410X
Subject:
Severe acute respiratory syndrome coronavirus 2; antibody formation; hospitals; longitudinal studies; vaccination; vaccines; South Korea
Abstract:
... To characterise the antibody response for 12 weeks following second dose of the Pfizer/BioNTech BNT162b2 mRNA vaccine in hospital workers of a Korean general hospital.We measured the level of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-receptor binding domain (anti-RBD) and neutralising antibodies every week in the first 4 weeks, and at weeks 8 and 12 following the second dos ...
DOI:
10.1016/j.vaccine.2021.12.012

10. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers

Author:
Karen Lutrick; Holly Groom; Ashley L. Fowlkes; Kimberly D Groover; Manjusha Gaglani; Patrick Rivers; Allison L. Naleway; Kimberly Nguyen; Meghan Herring; Kayan Dunnigan; Andrew Phillips; Joel Parker; Julie Mayo Lamberte; Khaila Prather; Matthew S. Thiese; Zoe Baccam; Harmony Tyner; Sarang Yoon
Source:
Vaccine 2022 v.40 no.3 pp. 494-502
ISSN:
0264-410X
Subject:
COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; occupations; sociodemographic characteristics; surveys; vaccination; vaccines; viruses
Abstract:
... In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.Initiated in July 2020, the HEROES-RECOVER cohort provided socio-demographics and COVID-19 vaccination data. Using two follow-up surveys approximately three months apart, COVI ...
DOI:
10.1016/j.vaccine.2021.11.094

11. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States

Author:
William L. Herring; Yuanhui Zhang; Vivek Shinde; Jeffrey Stoddard; Sandra E. Talbird; Brian Rosen
Source:
Vaccine 2022 v.40 no.3 pp. 483-493
ISSN:
0264-410X
Subject:
Respiratory syncytial virus; decision support systems; econometric models; economic valuation; influenza vaccination; mortality; prices; quality-adjusted life year; risk; vaccines; willingness to pay
Abstract:
... Respiratory syncytial virus (RSV) is an important cause of lower respiratory infections and hospitalizations among older adults. We aimed to estimate the potential clinical benefits and economic value of RSV vaccination of older adults in the United States (US).We developed an economic model using a decision-tree framework to capture outcomes associated with RSV infections in US adults aged ≥ 60 y ...
DOI:
10.1016/j.vaccine.2021.12.002

12. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status

Author:
François Helle; Julien Moyet; Baptiste Demey; Catherine François; Gilles Duverlie; Sandrine Castelain; Fréderic Bloch; Etienne Brochot
Source:
Vaccine 2022 v.40 no.3 pp. 531-535
ISSN:
0264-410X
Subject:
COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; humoral immunity; immune response; morbidity; mortality; seroprevalence; vaccines
Abstract:
... Coronavirus disease 2019 (COVID-19) is associated with increased morbidity and mortality in older adults. Although the advent of the first vaccines has significantly reduced these rates, data on older adults in clinical trials are scarce.We quantified and compared the humoral response in individuals with vs. without pre-existing seropositivity to severe acute respiratory syndrome coronavirus 2 (SA ...
DOI:
10.1016/j.vaccine.2021.11.086

13. Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine

Author:
Rachael K. Raw; Jon Rees; Clive A. Kelly; Caroline Wroe; David R. Chadwick
Source:
Vaccine 2022 v.40 no.3 pp. 418-423
ISSN:
0264-410X
Subject:
COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; antibodies; health services; vaccines; England
Abstract:
... The BNT162b2/Pfizer SARS-CoV-2 vaccine has been widely used in the UK, particularly amongst healthcare workers (HCWs). To establish whether previous COVID-19 influenced vaccine-associated Adverse Events (AEs), we conducted a survey-based study of HCWs in Northeast England. Out of 1238 HCWs, 32% self-reported prior positive PCR and/or antibody test for SARS-CoV-2. Post-dose AEs were worse in those ...
DOI:
10.1016/j.vaccine.2021.11.090

14. Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort

Author:
Emma M. de Koff; Marlies A. van Houten; Femke de Heij; Guy A.M. Berbers; Debby Bogaert; Elisabeth A.M. Sanders
Source:
Vaccine 2022 v.40 no.3 pp. 408-413
ISSN:
0264-410X
Subject:
Streptococcus pneumoniae; antibodies; fluorescence; immunoassays; immunoglobulin G; saliva; serotypes; vaccination; vaccines; Netherlands
Abstract:
... Pneumococcal conjugate vaccines reduce pneumococcal colonization via serotype-specific immunoglobulin G (IgG) at mucosal surfaces. The infant immunization schedule with the ten-valent pneumococcal conjugate vaccine (PCV10) changed from a 3 + 1 schedule (2–3-4–11 months) to a 2 + 1 schedule (2–4–11 months) in The Netherlands in 2013. We compared anti-pneumococcal IgG concentrations in saliva betwee ...
DOI:
10.1016/j.vaccine.2021.12.013

15. Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein

Author:
Brittani N. Blunck; Letisha Aideyan; Xunyan Ye; Vasanthi Avadhanula; Laura Ferlic-Stark; Lynn Zechiedrich; Brian E. Gilbert; Pedro A. Piedra
Source:
Vaccine 2022 v.40 no.3 pp. 536-543
ISSN:
0264-410X
Subject:
Respiratory syncytial virus; amino acids; antibody formation; antigens; blood serum; peptides; vaccines; viral fusion proteins
Abstract:
... The respiratory syncytial virus (RSV) fusion (F) protein undergoes two furin-cleavage events to become fusion competent, resulting in the release of a twenty-seven amino acid peptide (p27). Recent studies indicate that the p27 region of the F protein was an immunodominant antigen in young children. In this study, we evaluated the kinetics of the serum antibody response to the p27 peptide following ...
DOI:
10.1016/j.vaccine.2021.11.087

16. Development of a safe and effective novel synthetic mucosal adjuvant SF-10 derived from physiological metabolic pathways and function of human pulmonary surfactant

Author:
Takashi Kimoto
Source:
Vaccine 2022 v.40 no.3 pp. 544-553
ISSN:
0264-410X
Subject:
Influenza A virus; adjuvants; antigens; blood serum; cattle; gastrointestinal system; humans; influenza; influenza vaccines; lungs; macrophages; manufacturing; medicine; mucosa; nose; surface tension; surfactants; vaccination
Abstract:
... A safe and effective mucosal adjuvant is required for vaccination against influenza A virus (IAV) infection. Previously, we described that intranasally administration of surfacten®, a medicine derived from bovine pulmonary surfactant (PS), with IAV vaccine can induce IAV-specific IgA in the respiratory tract mucosa and IgG in serum. PS is secreted by alveolar type II cells and Clara cells and serv ...
DOI:
10.1016/j.vaccine.2021.11.030

17. Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)

Author:
Mark A. Katz; Efrat Bron Harlev; Bibiana Chazan; Michal Chowers; David Greenberg; Alon Peretz; Sagi Tshori; Joseph Levy; Mili Yacobi; Avital Hirsch; Doron Amichay; Ronit Weinberger; Anat Ben Dor; Elena Keren Taraday; Dana Reznik; Chen Barazani Chayat; Dana Sagas; Haim Ben Zvi; Rita Berdinstein; Gloria Rashid; Yonat Shemer Avni; Michal Mandelboim; Neta Zuckerman; Nir Rainy; Amichay Akriv; Noa Dagan; Eldad Kepten; Noam Barda; Ran D. Balicer
Source:
Vaccine 2022 v.40 no.3 pp. 512-520
ISSN:
0264-410X
Subject:
COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; health care workers; issues and policy; models; monitoring; nose; prospective studies; seroconversion; serology; vaccination; vaccines; Israel
Abstract:
... Methodologically rigorous studies on Covid-19 vaccine effectiveness (VE) in preventing SARS-CoV-2 infection are critically needed to inform national and global policy on Covid-19 vaccine use. In Israel, healthcare personnel (HCP) were initially prioritized for Covid-19 vaccination, creating an ideal setting to evaluate early real-world VE in a closely monitored population.We conducted a prospectiv ...
DOI:
10.1016/j.vaccine.2021.11.092

18. Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults

Author:
Ritthideach Yorsaeng; Nungruthai Suntronwong; Harit Phowatthanasathian; Suvichada Assawakosri; Sitthichai Kanokudom; Thanunrat Thongmee; Preeyaporn Vichaiwattana; Chompoonut Auphimai; Lakkhana Wongsrisang; Donchida Srimuan; Thaksaporn Thatsanatorn; Sirapa Klinfueng; Natthinee Sudhinaraset; Nasamon Wanlapakorn; Yong Poovorawan
Source:
Vaccine 2022 v.40 no.3 pp. 524-530
ISSN:
0264-410X
Subject:
COVID-19 infection; Severe acute respiratory syndrome coronavirus 2; blood serum; health services; immune response; immunogenicity; neutralization tests; public health; Thailand
Abstract:
... In June 2021, Thailand was hit by the delta variant of SARS-CoV-2 resulting in the biggest wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers had COVID-19 despite completion of two-dose CoronaVac. The Ministry of Public Health recommended that healthcare workers received a third dose of AZD1222 to increase level of protection against SARS-CoV-2. However, immune ...
DOI:
10.1016/j.vaccine.2021.11.083

19. Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012–2018

Author:
Joanne Lacy; Elise Tessier; Nick Andrews; Joanne White; Mary Ramsay; Michael Edelstein
Source:
Vaccine 2022 v.40 no.3 pp. 444-449
ISSN:
0264-410X
Subject:
childhood; ecological studies; vaccination; vaccines
Abstract:
... Vaccination coverage of dose two of MMR (MMR2) at 5th birthday has been consistently low in London and measured 76.3% in 2018/19. Since the early 2000s seven boroughs in London started offering dose two earlier, from 15 to 18 months onwards instead of the recommended 3 years 4 months. In this study we investigate whether the accelerated schedule of MMR2 leads to a change in coverage of MMR2 and ot ...
DOI:
10.1016/j.vaccine.2021.12.011

20. Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA)

Author:
Giorgia Sulis; Nicole E. Basta; Christina Wolfson; Susan A. Kirkland; Jacqueline McMillan; Lauren E. Griffith; Parminder Raina; on behalf of the Canadian Longitudinal Study on Aging (CLSA) Team
Source:
Vaccine 2022 v.40 no.3 pp. 503-511
ISSN:
0264-410X
Subject:
COVID-19 infection; influenza; influenza vaccination; influenza vaccines; longitudinal studies; odds ratio; pandemic; regression analysis; sociodemographic characteristics
Abstract:
... Understanding how influenza vaccine uptake changed during the 2020/2021 influenza season compared to previous pre-pandemic seasons is a key priority, as is identifying the relationship between prior influenza vaccination and COVID-19 vaccine willingness.We analyzed data from a large, nationally representative cohort of Canadian residents aged 50 and older to assess influenza vaccination status thr ...
DOI:
10.1016/j.vaccine.2021.11.088